One hundred and thirty-two Scottish families, representing the majority of currently known cases in this country with at least one living subject affected by DMD (110) or BMD (22), were studied with a series of cDNA probes excluding the 3' region of the gene (probes 10-14). Using mainly HindIII digested DNA from affected males, 89 patients showed deletions which ranged from 1 to 32 HindIII fragments in size. Two patients were also detected with exon duplications. Abnormalities were found to be particularly concentrated in the area of probe cDNA 8, with 56 patients being deleted for at least one of the fragments detected by this probe. A second smaller concentration of deletions was found with probe 1-2a which showed 16 deletions and two duplications. The endpoints of cDNA deletions or duplications were determined with a maximum variability of one HindIII fragment in 83 patients, while the remaining eight patients had a single deletion endpoint defined. The deletions found in two of our patients appear to conflict with the previously stated exon order at the 5' end of the gene. Although no specific deletion patterns were apparent for DMD, the deletions found in 13 of the BMD patients all included the most proximal (10 kb) fragment detected by probe 8. 
(BMD) result from mutations in the dystrophin gene. The cDNA sequence of the dystrophin gene has been determined2 and it has been shown to be composed of a minimum of 60 exons, as it detects 65 HindIII fragments and five HindlII sites are known to be present in the cDNA sequence.3 By subdividing the cDNA into lengths of approximately 1 kb, Koenig et a13 were able to deduce the 5' to 3' order of a significant number of the HindIII fragments, and to show that deletions were most common in the region of probes 7 and 8, a finding which has been confirmed by the results of other groups.6
We wish to report our analysis of DNA from 132 Scottish families with DMD or BMD using the cDNA probes isolated by Koenig et al. l These families represent the vast majority of cases in the entire country with a living or recently dead affected subject.
Patients and methods

PATIENTS
In Scotland there are 254 pedigrees known to have had at least one member affected by X linked muscular dystrophy. Samples from unrelated patients with DMD (110) or BMD (22) were referred to our laboratory as we have responsibility for carrier detection and prenatal diagnosis ofmuscular dystrophy as part of the Scottish molecular genetics consortium. Each case was clinically assessed and investigated in one of the genetics clinics associated with the Scottish consortium. Muscle histology was undertaken in each of the index cases reported in this paper, and DMD was differentiated from BMD using the age at which the patients became chairbound, as discussed by Emery.' None of the index cases of DMD was ambulant after 11 5 years of age, and of the BMD index patients the earliest age of loss of ambulation was 13-4 years.
Twenty-two pedigrees of definite BMD were ascertained after care was taken to exclude possible cases of autosomal recessive limb-girdle dystrophy. All index cases had calf hypertrophy and markedly raised serum creatine kinase (SCK) levels. Eight showed X linked inheritance, and one case with two affected sibs and three sporadic cases were included because female relatives were found to have carrier levels of SCK. A further isolated case was added after Analysis ofScotish Duchenne and Becker muscular dystrophy families with dystrophin cDNA probes The majority of the patients in this study were also investigated with a number of genomic probes: 754,7 HIP25,8 XJ series,9 pERT series,10 J-Bir," P20,'2 GMGX11,'3 and J66. '4 cDNA ANALYSIS Digests for cDNA analysis were carried out using (mainly) HindIII and BglII restriction enzymes and samples were run out on 1% agarose gels, 20 to 24 cm in length, to facilitate resolution of the numerous bands encountered with most of the cDNA probes. The smaller number of samples tested with probes 4-5a and 9 in particular is mainly a consequence of patients with an already defined deletion not being examined with these probes.
Seventeen patients were shown to be deleted for only a single HzndIII fragment, including five cases with a bandshift in an adjacent fragment. The largest deletion in our series (32 HindIII fragments) extends well beyond the DMD gene in the direction of the centromere (approximately 4 million base pairs in total) and was the subject of a previous report. 16 The largest deletion found that was contained within the boundaries of the DMD gene comprised 30 HindIII fragments. lll. 11 patients one endpoint was precisely defined with the other subject to a maximum variability of a single fragment. Three patients had one deletion endpoint proximal to exon 1, and two patients were negative for the most distal fragment detected by probe 9 
